No data available.
No data available.
| S.No. | Ticker | Company | Market Cap | P/E | P/S | Total Debt (Qtr) |
|---|---|---|---|---|---|---|
| 1 | ISRG | Intuitive Surgical Inc | 174.27 Bn | 61.02 | 17.31 | 0.00 Bn |
| 2 | BDX | Becton Dickinson & Co | 59.72 Bn | 37.77 | 3.14 | 19.18 Bn |
| 3 | RMD | Resmed Inc | 39.76 Bn | 26.76 | 7.37 | 0.85 Bn |
| 4 | ALC | Alcon Inc | 38.93 Bn | 37.18 | 3.82 | 5.24 Bn |
| 5 | WST | West Pharmaceutical Services Inc | 17.69 Bn | 133.13 | 12.54 | 0.30 Bn |
| 6 | HOLX | Hologic Inc | 16.81 Bn | 30.91 | 4.07 | 2.52 Bn |
| 7 | COO | Cooper Companies, Inc. | 16.37 Bn | 43.67 | 4.00 | 2.51 Bn |
| 8 | ALGN | Align Technology Inc | 13.73 Bn | 36.29 | 3.45 | 0.09 Bn |
| Current Valuation | Value | Ind Avg | Percentile |
|---|---|---|---|
| EV to Assets EV to Assets | 40.70 | 2.75 | |
| EV to Cash from Ops. EV/CFO | 541.54 | 39.87 | |
| EV to Debt EV to Debt | 0.00 | 27.09 | |
| EV to EBIT EV/EBIT | 437.67 | 32.86 | |
| EV to EBITDA EV/EBITDA | 564.62 | 19.31 | |
| EV to Free Cash Flow [EV/FCF] EV/FCF | 541.54 | 0.88 | |
| EV to Market Cap EV to Market Cap | 0.99 | -4.26 | |
| EV to Revenue EV/Rev | 162.80 | 252.61 | |
| Price to Book Value [P/B] P/B | 41.32 | 6.13 | |
| Price to Earnings [P/E] P/E | 442.24 | 184.03 |
| Dividend Metrics | Value | Ind Avg | Percentile |
|---|---|---|---|
| Dividend Coverage Ratio Dividend Coverage Ratio | 0.00 | -1.09 | |
| Dividend Payout Ratio % Dividend Payout Ratio % | 0.00 | 1.36 | |
| Dividend per Basic Share Div per Share (Qtr) | 0.00 | 0.25 | |
| FCF Dividend Payout Ratio % FCF Dividend Payout Ratio % | 0.00 | 8.74 | |
| Interest Coverage Interest Coverage | 0.00 | -117.83 |
| Growth Metrics | Value | Ind Avg | Percentile |
|---|---|---|---|
| Capex Growth (1y) % Capex Growth (1y) % | 0.00 | -53.47 | |
| Cash and Equivalents Growth (1y) % Cash & Equiv 1y % (Qtr) | -48.13 | 414.02 | |
| Dividend Growth (1y) % Dividend Growth (1y) % | 0.00 | -1.48 | |
| EBIAT Growth (1y) % EBIAT Growth (1y) % | -40.55 | -57.42 | |
| EBITDA Growth (1y) % EBITDA Growth (1y) % | 0.00 | -106.89 | |
| EBIT Growth (1y) % EBIT Growth (1y) % | -40.55 | -37.00 | |
| EBT Growth (1y) % EBT Growth (1y) % | -40.55 | -42.63 | |
| EPS Growth (1y) % EPS Growth (1y) % | 100.92 | -15.05 | |
| FCF Growth (1y) % FCF Growth (1y) % | 0.00 | 56.29 | |
| Gross Profit Growth (1y) % Gross Profit Growth (1y) % | 13.39 | 67.95 |
| Liquidity Ratios | Value | Ind Avg | Percentile |
|---|---|---|---|
| Asset Utilization Ratio Asset Utilization Ratio | 0.25 | 0.54 | |
| Cash Payout Ratio Cash Payout Ratio | 0.00 | 0.03 | |
| Cash Ratio Cash Ratio (Qtr) | 40.79 | 2.51 | |
| Current Ratio Curr Ratio (Qtr) | 211.10 | 7.80 | |
| Debt to Equity Ratio Debt/Equity (Qtr) | 0.00 | 0.55 | |
| Interest Cover Ratio Interest Cover Ratio | 0.00 | -117.83 | |
| Times Interest Earned Times Interest Earned | 0.00 | -117.83 |
| Profitability | Value | Ind Avg | Percentile |
|---|---|---|---|
| EBITDA Margin % EBITDA Margin % | 0.00 | -2,368.59 | |
| EBIT Margin % EBIT Margin % | 37.20 | -2,472.59 | |
| EBT Margin % EBT Margin % | 37.20 | -2,442.52 | |
| Gross Margin % Gross Margin % | 89.70 | 30.06 | |
| Net Profit Margin % Net Profit Margin % | 37.20 | -2,438.49 |